An infusion set that guarantees stability and immediacy of drug administration for preterm babies

Our in-silico platform can simulate stent-retriever-based thrombectomy in various patient-specific scenarios of varying vascular anatomy and clot characteristics. This allows the medical device industries to evaluate the performance of their novel devices before pre-clinical testing.

Invision-ex has developed a bioengineered, lab-grown, human cornea tissue, offering a sustainable, accessible, long-term, and vision corrective solution.

The Overkleeft group at Leiden University discovered superior proteasome inhibitors, and it is the aim of iProtics to develop these leads to become the first-in-line treatment for Multiple Myeloma patients.

To develop early-stage antibiotic lead compounds discovered by researchers at Utrecht University. Specifically, we aim to target clinically-relevant pathogenic bacteria that have become resistant to first-line antibiotics.

Molecular diagnostics products for chimerisme monitoring

Levels Dx is using activated immune cells as biomarkers to allow an accurate diagnosis of a bacterial infection in patients. The Rapid Diagnostic Tool (RDT) will provide accurate results within minutes and is portable.

Capsule Photonics developed LightUp: a pill-sized camera that detects more than 95% of early cancer by combining molecular imaging (Targeted Fluorescence) with high-resolution structural imaging (OCT).

We have developed a new, potent anticancer therapy with minimal side effects, as it has two levels of selectivity: a nanobody that directs a light-activatable drug to cancer cells, and light locally applied at the tumor to activate the drug.

Developing an innovative targeted immunotherapy against cancer using remote controlled conditional attenuated bacteria.